Our Pipeline


Developing a diversified product pipeline for integrated diagnostic, therapeutic and regenerative medicine. 


Theragnostic Technologies is actively pursuing strategies to develop and expand its exciting product portfolio. The company has a robust product pipeline, with multiple research, preclinical and preclinical IND (Investigational New Drug) candidates in development.

© Theragnostic Technologies, Inc. 2019


* Disclaimer:  Our products and technologies are currently not available for clinical use. FDA or other regulatory agencies have not evaluated the statements on this website regarding our products and technologies.